18 Best Pharma Startups in Switzerland to Watch in 2025

The Definitive Seedtable Ranking of Pharma Startups in Switzerland

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 18 start-ups with an aggregate funding of $1.6b. The average funding per company in this subset is $87.2m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

3

Funding Rounds

$52.0m

Money raised

3T Biosciences is a biotechnology company developing immunotherapies.

2

Funding Rounds

$1.0b

Money raised

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Location:

Key people:

7

Funding Rounds

$24.5m

Money raised

Immunophotonics is a company developing immunotherapy-based treatments for cancer founded in 2012 by Lu Alleruzzo.

Key people:

6

Funding Rounds

$15.8m

Money raised

Scailyte is a drug discovery and molecular diagnostics company developing molecular analytical tools for clinical applications.

1

Funding Rounds

$150.0m

Money raised

Neurimmune AG is a Schlieren, Zurich-based pharmaceutical company

3

Funding Rounds

$33.5m

Money raised

Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher.

Location:

Key people:

1

Funding Rounds

$16.9m

Money raised

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.

1

Funding Rounds

$11.1m

Money raised

A pharmaceutical company specializing in developing treatments for rare diseases

6

Funding Rounds

$6.2m

Money raised

Proprietary technology platform for the design and selection of GPCR-targeting compounds

2

Funding Rounds

$42.0m

Money raised

NBE Therapeutics is a Basel-based biotechnology company specializing in oncology. The company has developed an antibody drug conjugate platform targeting solid tumors.

6

Funding Rounds

Vaccines

1

Funding Rounds

$3.0m

Money raised

Analytical testing company focused on improving people's health.

1

Funding Rounds

$1.2m

Money raised

Novigenix is a Épalinges-based molecular diagnostics company developing blood tests for early detection of cancer founded in 2014.

1

Funding Rounds

$55.0m

Money raised

NousCom is a cancer Immunotherapies founded in 2015.

2

Funding Rounds

$100.0m

Money raised

Therachon is a company founded in 2014.

1

Funding Rounds

$11.7m

Money raised

Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .

Location:

Key people:

1

Funding Rounds

$27.5m

Money raised

Azafaros is a small Molecules.

1

Funding Rounds

$1.1m

Money raised

Laeverdoc is a Switzerland-based company.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.